Parag Saxena - Dec 18, 2024 Form SCHEDULE 13D/A Schedule Report for REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)

Filing Manager: SAXENA PARAG
Reporting Manager: Parag Saxena
Security: REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, $0.001 par value
Symbol: RVPH
Shares outstanding: 50.6M shares
Disclosed Ownership: 6.27M shares
Ownership: 12.4%
Form type: SCHEDULE 13D/A
Date filed: 1/31/2025, 09:31 PM
Date of event: Dec 18, 2024
SEC: View on sec.gov

Reporting Managers (5)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Vedanta Associates-R, LP	4.1%	1.97M	0	1.97M	By: Vedanta Partners, LLC, the general partner ("GP") of Vedanta Associates-R, L.P. /s/ Parag Saxena	Parag Saxena/CEO of Vedanta Partners, LLC	0001865703
Vedanta Associates, L.P.	6.9%	3.41M	0	3.41M	By: Vedanta Partners, LLC, the GP of Vedanta Associates, L.P. /s/ Parag Saxena	Parag Saxena/CEO of Vedanta Partners, LLC	0001502222
Beta Operators Fund, L.P.	4.4%	2.14M	0	2.14M	By: Vedanta Associates, L.P., the GP of Beta Operators Fund, L.P. By: Vedanta Partners, LLC, the GP of Vedanta Associates, L.P. /s/ Parag Saxena	Parag Saxena/CEO of Vedanta Partners, LLC	0001614642
VEDANTA PARTNERS, LLC	10.6%	5.38M	0	5.38M	/s/ Parag Saxena	Parag Saxena/CEO	0001502216
Parag Saxena	12.4%	6.27M	893K	5.38M	/s/ Parag Saxena	Parag Saxena/Individual	0001015823